We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Silver Falcon | LSE:SILF | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.75 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMSILF
RNS Number : 7722R
Silver Falcon PLC
26 September 2017
Silver Falcon Plc
(to become Hemogenyx Pharmaceuticals Plc)
Investor presentations
Silver Falcon Plc, (LSE: SILF), which has agreed to acquire the biotechnology company Hemogenyx Pharmaceuticals Limited ("Hemogenyx"), announces that it will be holding a series of meetings with investors regarding the opportunity presented to shareholders by the proposed acquisition of Hemogenyx LLC ("Hemogenyx").
The presentation will be led by Chief Executive Officer & Co-Founder of Hemogenyx, Dr Vladislav Sandler, with other Proposed Directors available for discussions after the formal presentation. The same presentation will be given at all events which are being held at different times to offer convenient options for those wishing to attend.
3 October 2017 - Lunchtime presentation hosted by Peterhouse Corporate Finance Limited
Hot Features
Premium
Time: 12.30pm - a sandwich lunch will be provided
Location: 3(rd) Floor New Liverpool House, 15 Eldon Street, London
EC2M 7LD
3 October 2017 - Afternoon Presentation hosted by Shard Capital Partners LLP
Time: 5pm - the presentation will be followed by drinks and
canapes
Location: 23(rd) Floor, 20 Fenchurch Street, London EC3M 3BY
4 October 2017 - Evening presentation hosted by Optiva Securities Limited
Time: 6pm - the presentation will be followed by drinks and
canapes
Location: Sartoria, 20 Savile Row, London W1S 3PR
For more information on the proposed acquisition see the Latest News section on: www.silverfalconplc.com
For a short video by Dr Sandler on Hemogenyx click here: www.brrmedia.co.uk/event/160159
If you would like to register for any of the investor presentations, or require further information, please contact Lianne Cawthorne at Walbrook PR on 020 7933 8780 or email hemogenyx@walbrookpr.com ensuring you detail in your email which presentation you would like to attend.
Hemogenyx Pharmaceuticals Limited www.hemogenyx.com Peter Redmond, Director Via Walbrook PR Optiva Securities Ltd Tel: +44 (0)20 3137 1902 Christian Dennis Shard Capital Partners LLP Tel: +44 (0)20 7186 9950 Damon Heath, Erik Woolgar Peterhouse Corporate Finance Limited Tel: +44 (0)20 7469 0930 Lucy Williams/Duncan Vasey Walbrook PR Tel: +44 (0)20 7933 8780 or hemogenyx@walbrookpr.com Paul McManus Mob: +44 (0)7980 541 893 Flowcomms IR Mob: +44 (0)7891 627 441 or sasha@flowcomms.com Sasha Sethi
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEAFNSALLXEAF
(END) Dow Jones Newswires
September 26, 2017 02:01 ET (06:01 GMT)
1 Year Silver Falcon Chart |
1 Month Silver Falcon Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
